✦ LIBER ✦
Additional Clinical Benefit for Patient Relevant Endpoints: Investment Disincentives by AMNOG in the Example of Parkinson’s Disease
✍ Scribed by Walzer, S.; Holbein, B.
- Book ID
- 122220220
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 76 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.